Clinical Trials Browser

Phase 2 × anetumab ravtansine × Other solid neoplasm × Clear all

NCT03926143 2023-08-04

A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies

Phase 2 Terminated

9 enrolled 10 charts

Other solid neoplasmThoracic

Mesothelioma

NCT02610140 2020-11-04

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Phase 2 Completed

248 enrolled 23 charts

Other solid neoplasmThoracic

Mesothelioma